-
MetLife Arm MIM Secures $1.2B for 2nd Private Equity Fund
2024 Jul 10, 1:09pm | 611MetLife, Inc.'s (NYSE: MET) institutional asset management arm, MetLife Investment Management ("MIM"), recently launched its second private equity fund, MetLife Investment Private Equity Partners II, securing around $1.2 billion in commitments. This new fund, aimed at institutional...
-
DuPont Tyvek Richmond Facility Gets ISCC+ Certification
2024 Jul 10, 11:21am | 658DuPont de Nemours Inc. (NYSE: DD) announced that its Tyvek production facility at the Spruance manufacturing plant in Richmond has achieved certification from the International Sustainability and Carbon Certification (ISCC PLUS). The Spruance site is the second DuPont location to obtain ISCC...
-
Here's Why You Should Hold Onto CF Industries Stock for Now
2024 Jul 10, 11:15am | 706CF Industries Holdings, Inc. (NYSE: CF) is poised to gain from higher nitrogen fertilizer demand in major markets and lower natural gas costs amid headwinds from softer nitrogen prices. The company's shares have declined 4.1% over a year compared with a 25.3% decline of its industry. Image...
-
Why You Should Retain DuPont Stock in Your Portfolio
2024 Jul 09, 12:23pm | 748DuPont de Nemours, Inc. (NYSE: DD) is expected to benefit from its innovation-driven investment, productivity actions and the acquisition of the Spectrum Plastics Group. However, it faces headwinds from certain challenges including weaker demand in specific businesses. The company's shares are...
-
Here's Why You Should Hold Onto Celanese Stock for Now
2024 Jul 09, 12:18pm | 853Celanese Corporation (NYSE: CE) is expected to benefit from its investments in high-return organic projects, cost and productivity actions and synergies of acquisitions. However, it faces headwinds from weak demand in certain end markets and pricing pressures. The company's shares have gained...
-
Should You Retain Trupanion Stock in Your Portfolio?
2024 Jul 08, 12:26pm | 833Trupanion, Inc. (NASDAQ: TRUP) has been benefiting from a focus on pet health and well-being in an underpenetrated pet insurance market, product launches, extended operating boundaries, as well as sufficient liquidity. Growth Projections The Zacks Consensus Estimate for Trupanion's 2024...
-
Natural Gas Markets Endure a Rocky Week: What Happened?
2024 Jul 08, 12:18pm | 901The U.S. Energy Department's weekly inventory release showed that natural gas supplies increased more than expected. The bearish inventory numbers, together with signs of production gains, affected natural gas futures, which settled with a heavy loss week over week. Meanwhile, forecasts for...
-
5 Financial Transaction Stocks in Focus Amid Digital Payment Boom
2024 Jul 05, 3:02pm | 1960The Financial Transaction Services industry is poised to benefit from the increasing adoption of digital solutions. A robust digital offering allows industry players to leverage this trend effectively. Favorable consumer spending patterns are expected to drive transaction volumes higher. To...
-
Quest Diagnostics to Expand in Canada With LifeLabs Buyout
2024 Jul 05, 12:46pm | 837Quest Diagnostics (NYSE: DGX) has entered into a definitive agreement with OMERS to acquire LifeLabs, a prominent Canadian provider of community laboratory tests. The deal, valued at approximately CAN $1.35 billion ($985 million), underscores DGX's strategy to expand its footprint in Canada...
-
Cirrus Logic Soars 54.6% YTD: Will the Upside Last?
2024 Jul 05, 11:44am | 884Cirrus Logic, Inc.'s (NASDAQ: CRUS) stock is continuing its upward trajectory, with a gain of 54.6% year to date (YTD) compared with 16.7% and 31.7% growth of the S&P 500 composite and the sub-industry, respectively. Cirrus Logic is a fabless semiconductor supplier that develops low-power,...
-
Should You Retain Markel Group Stock in Your Portfolio?
2024 Jul 03, 12:23pm | 802Markel Group Inc. (NYSE: MKL) has been gaining momentum on the back of new business volume, strong retention levels, an improving rate environment, higher interest income on cash equivalents, strategic buyouts and favorable growth estimates. Growth Projections The Zacks Consensus Estimate for...
-
Neuronetics Expands NeuroStar Portfolio With New Launch
2024 Jul 02, 4:08pm | 809Neuronetics, Inc. (NASDAQ: STIM) recently announced the nationwide launch of the Better Me Provider (BMP) program. The BMP program will be a part of the company's NeuroStar product line. The providers participating in the program are expected to maintain correct standards, developed in...
-
Mesoblast Soars 208% YTD on Positive Regulatory Updates
2024 Jul 02, 1:31pm | 740Mesoblast Limited (NASDAQ: MESO) has witnessed a phenomenal run in the year so far. Shares of MESO have risen a whopping 208.2% year to date against the industry's decline of 6.3%. The massive outperformance can mostly be attributed to positive regulatory updates. Image Source: Zacks...
-
Can Constellation Brands Beat Q1 Earnings Amid High Costs?
2024 Jun 28, 3:05pm | 916Constellation Brands, Inc. (NYSE: STZ) is scheduled to release first-quarter fiscal 2025 results on Jul 3, 2024. The alcoholic beverage bigwig is expected to have recorded top and bottom-line growth in the to-be-reported quarter. The Zacks Consensus Estimate for the company's fiscal first-...
-
Merck's New Pneumococcal Jab Capvaxive Gets CDC Panel Vote
2024 Jun 28, 12:34pm | 780Merck (NYSE: MRK) announced that the U.S. Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) has unanimously voted to recommend MRK's newly approved 21-valent pneumococcal conjugate vaccine (PCV) Capvaxive. The FDA approved Capvaxive...
Coverage of Earnings Beats.